Russell Investments Group
IMGN

Russell Investments Group’s Immunogen Inc IMGN Stock Holding History

Russell Investments Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,134
Closed -$449K – 3400
2023
Q4 		$449K Sell
15,134
-2,459
-14% -$49K ﹤0.01% 2254
2023
Q3 		$279K Buy
17,593
+2,607
+17% +$43.4K ﹤0.01% 2415
2023
Q2 		$283K Sell
14,986
-29,814
-67% -$352K ﹤0.01% 2393
2023
Q1 		$172K Sell
44,800
-7,400
-14% -$31.5K ﹤0.01% 2504
2022
Q4 		$259K Buy
52,200
+37,300
+250% +$202K ﹤0.01% 2505
2022
Q3 		$71K Hold
14,900
– – ﹤0.01% 2715
2022
Q2 		$67K Hold
14,900
– – ﹤0.01% 2714
2022
Q1 		$70K Hold
14,900
– – ﹤0.01% 2606
2021
Q4 		$110K Hold
14,900
– – ﹤0.01% 2828
2021
Q3 		$84K Hold
14,900
– – ﹤0.01% 2905
2021
Q2 		$98K Hold
14,900
– – ﹤0.01% 3060
2021
Q1 		$120K Sell
14,900
-98,119
-87% -$801K ﹤0.01% 2943
2020
Q4 		$728K Sell
113,019
-5,271
-4% -$30.7K ﹤0.01% 2265
2020
Q3 		$424K Buy
118,290
+45,978
+64% +$186K ﹤0.01% 2467
2020
Q2 		$329K Sell
72,312
-79,625
-52% -$339K ﹤0.01% 2545
2020
Q1 		$519K Buy
151,937
+79,837
+111% +$349K ﹤0.01% 2155
2019
Q4 		$368K Buy
72,100
+71,200
+7,911% +$242K ﹤0.01% 2509
2019
Q3 		$2K Buy
+900
New +$2.39K ﹤0.01% 3009
2018
Q3 		– Sell
-145,115
Closed -$1.41M – 3034
2018
Q2 		$1.41M Sell
145,115
-12,557
-8% -$132K ﹤0.01% 1939
2018
Q1 		$1.66M Buy
157,672
+53,644
+52% +$530K ﹤0.01% 1960
2017
Q4 		$695K Buy
104,028
+8,108
+8% +$50K ﹤0.01% 2317
2017
Q3 		$734K Sell
95,920
-26,701
-22% -$177K ﹤0.01% 2288
2017
Q2 		$872K Buy
+122,621
New +$561K ﹤0.01% 2182

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's IMGN Position: Q1 2024 in Review

Russell Investments Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 15,134 shares — an estimated $449K sold.

Russell Investments Group first reported a position in IMGN in Q2 2017 and held it in 23 quarters. The position peaked at $1.66M in Q1 2018. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Russell Investments Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Russell Investments Group sold 15,134 Immunogen Inc shares in Q1 2024, an estimated $449K.
  • Russell Investments Group first reported a position in Immunogen Inc in Q2 2017 and held it in 23 quarters.
  • Russell Investments Group's Immunogen Inc position peaked at $1.66M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.